Cencora, Inc. COR

Revenue Intelligence Report • 58 quarters of SEC filing data • Updated 2026-03-15

In our econometric model, COR’s FY revenue growth of 9.6% sits atop an operating structure where SG&A efficiency translates into outsized revenue leverage, evidenced by SG&A ROI of $26.22 per $1 spent. This elasticity suggests incremental SG&A spend—covering sales, marketing, and logistics—drives growth through volume gains and network coverage rather than material price or R&D push, fitting a capital-light, distribution model. The holdout test is exceptionally reliable: predicted $85.9B vs actual $85.9B with about -0.1% error, and a 3.5% MAPE over 58 quarters underscores forecast robustness. Risks to this growth pace include sensitivity to supply-chain disruptions, payer negotiations, and regulatory shifts that could erode margins if volumes or pricing power deteriorate.

Investment Thesis

The econometric model achieves strong accuracy (3.5% MAPE), suggesting Cencora, Inc.'s revenue trajectory is well-characterized by its spending patterns. Each $1 of SG&A spending generates $26.22 in revenue, reflecting strong commercial efficiency.

Next FY Revenue
$354.7B
+9.6% YoY
SG&A Multiplier
$26.22 per $1
Model Accuracy
3.5% MAPE
Holdout validation: The model predicted $86B vs the actual $86B — an error of 0.1%.
Note: Cencora, Inc. does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

COR Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q3 2025 $86B $86B $83B – $89B +15.7% ✓ In range
Q4 2025 $83B $79B – $88B +2.1%
Q1 2026 $88B $82B – $93B +16.2%
Q2 2026 $92B $86B – $99B +14.5%
Q3 2026 $92B $84B – $99B +6.5%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Cencora, Inc.'s systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 0.9509 -4.9% -4.9% below trend 5
FQ2 (Dec–Feb) 1.0161 +1.6% In line with trend 17
FQ3 (Mar–May) 0.98 -2.0% In line with trend 16
FQ4 (Jun–Aug) 1.0025 +0.2% In line with trend 16

How Spending Drives Revenue

COR Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

MCK EW ABBV BSX BIIB HOLX VRTX ISRG